semaglutide type 1 diabetes automated insulin delivery randomized trial 2025 Late breaking at #EASD2024: In the phase 3 QWINT-2 trial, adults with 2 who had not previously received were assigned to receive once-weekly efsitora or once-daily degludec. Efsitora was Effectiveness and Safety of Semaglutide

Semaglutide & Tirzepatide: Leading Weight Loss Medications What is Semaglutide

Final Thought: While where you inject Semaglutide doesnt drastically change its effectiveness, it can impact your comfort and experience

Additional regulations None Vermont Who can prescribe semaglutide

What is the product used for

Learning Objectives After completing this application-based continuing education activity, pharmacists will be able to After completing this application-based continuing education activity, pharmacy technicians will be able to Release Date: December 1, 2025 Expiration Date: December 1, 2028 Course Fee Pharmacists: $7 Pharmacy Technicians: $4 There is no grant funding for this CE activity ACPE UANs Pharmacist: 0009-0000-25-072-H05- P Pharmacy Technician: 0009-0000-25-072-H05- T Session Codes Pharmacist: 22YC65-ABC23 Pharmacy Technician: 22YC65-CBA32 Accreditation Hours 2.0 hours of CE Accreditation Statements Disclosure of Discussions of Off-label and Investigational Drug Use The material presented here does not necessarily reflect the views of The University of Connecticut School of Pharmacy or its co-sponsor affiliates

Administration of single-dose rosuvastatin with oral semaglutide at steady state resulted in a 41% increase in AUC 0 and a 10% increase in C max for rosuvastatin compared with patients not receiving oral semaglutide